EDAP TMS S.A. (FOCL)
NASDAQ: FOCL Ā· Real-Time Price Ā· USD
2.610
-0.210 (-7.45%)
Nov 20, 2026, 4:00 PM EST - Market closed
EDAP TMS Revenue
EDAP TMS had revenue of $12.20M in the quarter ending September 30, 2026, with 21.42% growth. This brings the company's total for the last twelve months to $83.58M, up 52.08% year-over-year. In the year 2025, EDAP TMS had annual revenue of $70.53M with 5.71% growth. That makes EDAP TMS the 24,320th largest company in the world by revenue and 3,426th in the United States.
Revenue (ttm)
$83.58M
Revenue Growth
+52.08%
P/S Ratio
1.52
Revenue / Employee
$281,360
Employees
289
Market Cap
123.25M
Revenue by Segment
Fiscal year ended Dec 31, 2025 See the full EDAP TMS breakdown
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 70.53M | 3.81M | 5.71% |
| Dec 31, 2024 | 66.71M | -80.09K | -0.12% |
| Dec 31, 2023 | 66.79M | 7.68M | 13.00% |
| Dec 31, 2022 | 59.11M | 9.00M | 17.97% |
| Dec 31, 2021 | 50.11M | -630.82K | -1.24% |
| Dec 31, 2020 | 50.74M | 348.28K | 0.69% |
| Dec 31, 2019 | 50.39M | 5.36M | 11.91% |
| Dec 31, 2018 | 45.03M | 2.14M | 4.98% |
| Dec 31, 2017 | 42.89M | 5.42M | 14.47% |
| Dec 31, 2016 | 37.47M | 2.45M | 6.99% |
| Dec 31, 2015 | 35.02M | 2.61M | 8.06% |
| Dec 31, 2014 | 32.41M | -705.63K | -2.13% |
| Dec 31, 2013 | 33.11M | -1.27M | -3.69% |
| Dec 31, 2012 | 34.38M | 5.52M | 19.14% |
| Dec 31, 2011 | 28.86M | -2.84M | -8.96% |
| Dec 31, 2010 | 31.70M | -3.98M | -11.17% |
| Dec 31, 2009 | 35.68M | 3.55M | 11.06% |
| Dec 31, 2008 | 32.13M | -508.42K | -1.56% |
| Dec 31, 2007 | 32.64M | 5.97M | 22.39% |
| Dec 31, 2006 | 26.66M | 2.08M | 8.44% |
| Dec 31, 2005 | 24.59M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| McKesson | 418.79B |
| Cencora | 337.40B |
| Cardinal Health | 257.75B |
| Henry Schein | 13.73B |
| 111, Inc. | 1.54B |
| Cosmos Health | 73.73M |
| Akso Health Group | 13.83M |
| Cellyan Biotechnology | 13.43M |
FOCL News
- 11 days ago - EDAP TMS Transcript: UBS Global Healthcare Conference - Transcripts
- 16 days ago - FocalTherics price target lowered to $8 from $10 at Lucid Capital - TheFly
- 16 days ago - EDAP TMS Earnings Call Transcript: Q3 2026 - Transcripts
- 16 days ago - EDAP TMS Quarterly report: Q3 2026 - Filings
- 16 days ago - EDAP TMS Earnings release: Q3 2026 - Filings
- 16 days ago - FocalTherics⢠Reports Third Quarter 2026 Financial Results - GlobeNewsWire
- 17 days ago - FocalTherics⢠to Participate in Upcoming Investor Conferences - GlobeNewsWire
- 4 weeks ago - FocalTherics⢠to Announce Third Quarter 2026 Financial Results on November 5, 2026 - GlobeNewsWire